This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Walgreens-Rite Aid review by FTC examines preferred provider Wal-Mart as competitor

By Matthew Newman ( June 8, 2017, 18:56 GMT | Insight) -- In their review of the Walgreens-Rite Aid deal, US regulators are examining the impact of Walmart as a competitor when it is used as a preferred provider in a health insurer's drug plan, according to a Federal Trade Commission document. US healthcare insurer Humana has been ordered to supply documents about its Walmart Rx Plan by June 15, according to FTC documents made available Wednesday.In their review of the Walgreens-Rite Aid deal, US regulators are examining the impact of Walmart as a competitor when it is used as a sole preferred provider in a health insurer's drug plan, according to a Federal Trade Commission document....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login